Press Release Aegis Life and Entos Complete Phase 1 Enrollment of Clinical Trial for COVID-19 Vaccine Booster Covigenix VAX-002 shows significant promise as a novel DNA vaccine to stimulate immunity against circulating strains of SARS-CoV-2 in animal models Data published in the print edition of Cell today describes the